Abstract
ABSTRACT
Infections from Clostridioides difficile (often called C. diff) have long presented challenges for both patients and clinicians. Traditionally, C. diff has been considered a nosocomial infection, but in recent years, a noticeable spike in community-acquired cases has occurred. C. diff infection (CDI) testing is often complicated, as various testing options with differing sensitivity and specificity for active infection are available. Also, recent guideline changes have altered the recommended treatment of infection. This article discusses recent changes to both the diagnosis and management of CDI and how they can be applied to everyday NP practice.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference21 articles.
1. The burden of CDI in the United States: a multifactorial challenge;Feuerstadt;BMC Infect Dis,2023
2. Changes in prevalence of health care-associated infections in U.S. hospitals;Magill;N Engl J Med,2018
3. ACG clinical guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections [published correction appears in Am J Gastroenterol. 2022;117(2):358];Kelly;Am J Gastroenterol,2021
4. A review of Clostridioides difficile infection and antibiotic-associated diarrhea;Abad;Gastroenterol Clin North Am,2021
5. Community-acquired Clostridium difficile: epidemiology, ribotype, risk factors, hospital and intensive care unit outcomes, and current and emerging therapies;Ofori;J Hosp Infect,2018